SCHEMBL5791598

SCHEMBL5791598

O=CC(Br)C1(c2ccc(I)cc2)CC1

nearest known ligand 0.33

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
GSK3B P49841 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19207558 0.81 HDAC4 (0.39)
SCHEMBL3408485 0.75 SLC6A4 (0.47)
SCHEMBL3408732 0.75 SLC6A4 (0.51)
SCHEMBL16516607 0.74 HDAC4 (0.40)
SCHEMBL3413223 0.74 SLC6A4 (0.54)
SCHEMBL6259078 0.71 SLC6A3 (0.40) GSK3B
SCHEMBL4283467 0.68 SLC6A4 (0.55)
SCHEMBL7366122 0.68 SLC6A4 (0.55)
SCHEMBL7047850 0.68 SLC6A4 (0.51)
SCHEMBL7388 0.67 OPRM1 (0.34)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1505966-A4 1,1-DISUBSTITUTED CYCLOALKYL DERIVATIVES AS FACTOR XA INHIBITORS BRISTOL MYERS SQUIBB CO (US) 2006-08-30 EP disclosed
EP-1505966-A1 1,1-DISUBSTITUTED CYCLOALKYL DERIVATIVES AS FACTOR XA INHIBITORS Bristol-Myers Squibb Company (US) 2005-02-16 EP disclosed
WO-2003099276-A1 1,1-DISUBSTITUTED CYCLOALKYL DERIVATIVES AS FACTOR XA INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2003-12-04 WO disclosed